A survey of fever management for febrile intensive care patients without neurological injury

Critical Care and Resuscitation

Volumn 13, Issue 4, 2011, Pages 238-243

  Saxena, Manoj K ^a,b,c   Hammond, Naomi E ^a,c   Taylor, Colman ^a,d   Young, Paul ^e   Reade, Michael C ^f,g   Bellomo, Rinaldo ^f   Myburgh, John ^a,b,c  

^a GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^b ST GEORGE HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e MEDICAL RESEARCH INSTITUTE OF NEW ZEALAND   (New Zealand)

^f AUSTIN HOSPITAL   (Australia)

^g UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; PARACETAMOL;

ARTICLE; CRITICAL ILLNESS; FEVER; HEALTH CARE SURVEY; HEALTH PERSONNEL ATTITUDE; HUMAN; INTENSIVE CARE UNIT; SEPSIS;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ATTITUDE OF HEALTH PERSONNEL; CRITICAL ILLNESS; FEVER; HEALTH CARE SURVEYS; HUMANS; INTENSIVE CARE UNITS; SEPSIS;

EID: 84857089162     PISSN: 14412772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Circiumaru B, Baldock G, Cohen J. A prospective study of fever in the intensive care unit. Intensive Care Med 1999; 25: 668-73.
2. Ryan M, Levy M. Clinical review: fever in intensive care unit patients. Crit Care 2003; 7: 221-5.
3. Laupland KB, Shahpori R, Kirkpatrick AW, et al. Occurrence and outcome of fever in critically ill adults. Crit Care Med 2008; 36: 1531-5.
4. Barie PS, Hydo LJ, Eachempati R. Causes and consequences of fever complicating critical surgical illness. Surg Infect (Larchmt) 2004; 5: 145-59.
5. Azocar J, Yunis EJ, Essex M. Sensitivity of human natural killer cells to hyperthermia. Lancet 1982; 1: 16-7.
6. Bernheim HA, Kluger MJ. Fever: effect of drug-induced antipyresis on survival. Science 1976; 193: 237-9.
7. Biggar WD, Bohan DJ, Kent G, et al. Neutrophil migration in vitro and in vivo during hypothermia. Infect Immun 1984; 46: 857-9.
8. Jampel HD, Duff GW, Gershon RK, et al. Fever and immunoregulation: III. Hyperthermia augments the primary in vitro humoral immune response. J Exp Med 1983; 157: 1229-38.
9. Kluger MJ, Ringler DH, Anver MR. Fever and survival. Science 1975; 188: 166-8.
10. Bernard GR, Wheeler AP, Russell JA, et al. The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med 1997; 336: 912-8.
11. Manthous CA, Hall JB, Olson D, et al. Effect of cooling on oxygen consumption in febrile critically ill patients. Am J Resp Crit Care Med 1995; 151: 10-4.
12. Busto R, Dietrich W, Globus M, Ginsberg M. The importance of brain temperature in cerebral ischemic injury. Stroke 1989; 20: 1113-4.
13. Diringer MN, Reaven N, Funk S, Uman G. Elevated body temperature independently contributes to increased length of stay in neurologic intensive care patients. Crit Care Med 2004; 32: 1489-95.
14. Greer D, Funk S, Reaven N, et al. Impact of fever on outcome in patients with stroke and neurologic injury: a comprehensive metaanalysis. Stroke 2008; 39: 3029-35.
15. Hammond NE, Boyle M. Pharmacological versus non-pharmacological antipyretic treatments in febrile critically ill patients: a systematic review and meta-analysis. Aust Crit Care 2011; 24: 4-17.
16. Schulman CI, Namias N, Doherty J, et al. The effect of antipyretic therapy upon outcomes in critically ill patients: a randomized, prospective study. Surg Infect (Larchmt) 2005; 6: 369-75.
17. Saxena M, Andrews P, Cheng A. Modest cooling therapies (35 degrees C to 37.5 degrees C) for traumatic brain injury. Cochrane Database Syst Rev 2008; (3): CD006811.
18. Jefferies S, Weatherall M, Young P, et al. The effect of antipyretic medications on mortality in critically ill patients with infection: a systematic review and meta-analysis. Crit Care Resusc 2011; 13: 125-31.
19. Dellinger RP, Levy MM, Cartlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008; 34: 17-60.
20. Guidelines for the management of severe traumatic brain injury. J Neurotrauma 2007; 24: s1-117.
21. O'Grady NP, Barie PS, Bartlett J, et al. Practice parameters for evaluating new fever in critically ill adult patients. Task Force of the American College of Critical Care Medicine of the Society of Critical Care Medicine in collaboration with the Infectious Disease Society of America. Crit Care Med 1998; 26: 392-408.
22. O'Grady NP, Barie PS, Bartlett JG, et al; American College of Critical Care Medicine; Infectious Diseases Society of America. Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America. Crit Care Med 2008; 36: 1330-49.
23. Gozzoli V, Treggiari MM, Kleger GR, et al. Randomized trial of the effect of antipyresis by metamizol, propacetamol or external cooling on metabolism, hemodynamics and inflammatory response. Intensive Care Med 2004; 30: 401-7.
24. Morris PE, Promes JT, Guntupalli KK, et al. A multi-center, randomized, double-blind, parallel, placebo-controlled trial to evaluate the efficacy, safety, and pharmacokinetics of intravenous ibuprofen for the treatment of fever in critically ill and non-critically ill adults. Crit Care 2010; 14: R125.
25. Dubois E. Why are temperatures over 106 degrees F rare? Am J Med Sci 1949; 217: 361-8.
26. Mackowiak P. Fever: blessing or curse? A unifying hypothesis. Ann Intern Med 1994; 120: 1037-40.
27. Thompson HJ, Mitchell PH, Webb DJ. Fever management practices of neuroscience nurses: national and regional perspectives. J Neurosci Nurs 2007; 39: 151-62.
28. Johnston N, King A, Protheroe R, Childs C. Body temperature management after severe traumatic brain injury: methods and protocols used in the United Kingdom and Ireland. Resuscitation 2006; 70: 254-62.
29. Young P, Saxena M, Eastwood G, et al. Fever and fever management among intensive care patients with known or suspected infection: a multicentre prospective cohort study. Crit Care Resusc 2011; 13: 97-102.
30. Gore I, Isaacson NH. The pathology of hyperpyrexia: observations at autopsy of 17 cases of fever therapy. Am J Pathol 1949; 25: 1029-59.
31. Jorgensen H, Reith J, Nakayama H, et al. Potentially reversible factors during the very acute phase of stroke and their impact on the prognosis: is there a large therapeutic potential to be explored? Cerebrovasc Dis 2001; 11: 207-11.
32. Stocchetti N, Rossi S, Zanier E, et al. Pyrexia in head-injured patients admitted to intensive care. Intensive Care Med 2002; 28: 1555-62.
33. Launey Y, Nesseler N, Malledant Y, Seguin P. Clinical review: fever in septic ICU patients-friend or foe? Crit Care 2011; 15: 222-9.
34. Peabody J, Luck J, Glassman P, et al. Measuring the quality of physician practice by using clinical vignettes: a prospective validation study. Ann Intern Med 2004; 141: 771-80.
35. Moran J, Peter J, Solomon P, et al. Tympanic temperature measurements: are they reliable in the critically ill? A clinical study of measures of agreement. Crit Care Med 2007; 35: 155-64.